Literature DB >> 21602418

Is it safe to perform coronary angiography during acute endocarditis?

Victor W S Kung1, Omar A Jarral, Alex R Shipolini, David J McCormack.   

Abstract

A best evidence topic was written according to a structured protocol. The question addressed was 'Is it safe to perform coronary angiography (CA) in acute endocarditis?' Three hundred and ninety-seven papers were found using the reported search, of which six represented the best evidence to answer the clinical question. The authors, journal, date and country of publication, patient group studied, study type, relevant outcomes, key results and limitations of these papers are tabulated. One of the papers is a case report, which reported a fatal vegetation embolism from an infected aortic valve into the left main coronary artery 14 h after angiography. The remaining five papers are cohort studies. Four of these studies were performed between 1970 and 1980 before the era of echocardiography and were aimed at quantifying the severity of valvular regurgitation. No embolic complications or dislodgement of vegetations occurred in any of the five studies (186 patients). Guidelines published by the European Society of Cardiology (ESC) in 2009 recommended CA in the context of infective endocarditis (IE) for men >40 years old, postmenopausal women, and patients with at least one cardiovascular risk factor or a history of coronary artery disease. Exceptions include patients with large aortic vegetations which may be dislodged during catheterisation, and when emergency surgery is necessary - 1) native aortic or mitral IE with severe acute regurgitation or valve obstruction, or prosthetic valve IE with severe prosthetic dysfunction (dehiscence or obstruction) causing refractory pulmonary oedema or cardiogenic shock; 2) native aortic, mitral, or prosthetic valve IE with fistula into a cardiac chamber or pericardium causing refractory pulmonary oedema or shock. This is reiterated by the guidelines on the management of valvular heart disease published by the ESC in 2007. From the findings of the six papers, it can be concluded that coronary angiography can be performed safely in IE and should be performed if deemed necessary, unless the patients are haemodynamically unstable requiring emergency surgery, or have large vegetations of the aortic valve. This is consistent with the ESC guidelines.

Entities:  

Mesh:

Year:  2011        PMID: 21602418     DOI: 10.1510/icvts.2011.269035

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  5 in total

1.  [Dehiscence of an aortic valve with consecutive high grade aortic insufficiency and cardiac shock. A rare complication of prosthetic valve endocarditis].

Authors:  T Butz; P Maagh; C Schilling; R Wennemann; H Yeni; A Meissner; G Plehn; H-J Trappe
Journal:  Herz       Date:  2012-07-08       Impact factor: 1.443

2.  Preoperative evaluation for coronary atherosclerosis with computed tomography angiography in intravenous drug users: an emerging indication in the face of a growing threat.

Authors:  Anand M Prabhakar; Pedro V Staziaki; Richard A P Takx; Brian B Ghoshhajra
Journal:  Int J Cardiovasc Imaging       Date:  2015-07-25       Impact factor: 2.357

3.  Screening for coronary artery disease in early surgical treatment of acute aortic valve infective endocarditis.

Authors:  Wiebe G Knol; Ali R Wahadat; Jolien W Roos-Hesselink; Nicolas M Van Mieghem; Wilco Tanis; Ad J J C Bogers; Ricardo P J Budde
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-04-19

4.  Prosthetic valve endocarditis: A challenging complication of prosthetic valves.

Authors:  Bilgin Emrecan; Hayati Taştan; Şafak Şimşek; Kadir Çekirdekoğlu
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2019-04-24       Impact factor: 0.332

5.  Surgical outcomes in native valve infectious endocarditis: the experience of the Cardiovascular Surgery Department - Cluj-Napoca Heart Institute.

Authors:  Adrian Molnar; Ioan Muresan; Catalin Trifan; Dana Pop; Diana Sacui
Journal:  Clujul Med       Date:  2015-07-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.